Robert R. Shenk

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET.

Lee P. Adler, P. Faulhaber, K C Schnur et al. · Radiology · 1997 · 177 citations

Medicine, Nuclear Medicine, Oncology +15

Relationship Between the Size and Margin Status of Ductal Carcinoma In Situ of the Breast and Residual Disease

Nadia Al‐Kaisi, Fadi Gebrail, Robert R. Shenk et al. · JNCI Journal of the National Cancer Institute · 1997 · 109 citations

Medicine, Pathology, Surgery +15

Positron emission tomography and breast masses: Comparison with clinical, mammographic, and pathological findings

Joseph P. Crowe, Lee P. Adler, Robert R. Shenk et al. · Annals of Surgical Oncology · 1994 · 104 citations

Medicine, Nuclear Medicine, Radiology +16

Estrogen receptor determination and long term survival of patients with carcinoma of the breast.

Joseph P. Crowe, Nahida H. Gordon, Charles A. Hubay et al. · PubMed · 1991 · 49 citations

Medicine, Endocrinology, Oncology +15